Informed-money record

NKTR · NEKTAR THERAPEUTICS

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

2

Bearish filings

56

Named actors

7

Disclosed $ (bull / bear)

$0 / $10.8M

Recent disclosures

25 of 58 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-06-30Chief R&D Officer Zalevsky Jonathansold$398KSEC ↗
2026-06-30Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JONATHAN ZALEVSKYfiled notice to sell$371KSEC ↗
2026-06-17Officer (via Fidelity Brokerage Services LLC) ROBIN HOWARD Wfiled notice to sell$603KSEC ↗
2026-06-16Officer (via Fidelity Brokerage Services LLC) ROBIN HOWARD Wfiled notice to sell$610KSEC ↗
2026-06-15Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JONATHAN ZALEVSKYfiled notice to sell$329KSEC ↗
2026-05-19President & CEO ROBIN HOWARD Wsold$29KSEC ↗
2026-05-19Chief R&D Officer Zalevsky Jonathansold$13KSEC ↗
2026-05-19Officer (via Fidelity Brokerage Services LLC) ROBIN HOWARD Wfiled notice to sell$29KSEC ↗
2026-05-19Officer (via Fidelity Brokerage Services LLC) Zalevsky Jonathanfiled notice to sell$13KSEC ↗
2026-05-08Issuer (share issuance)priced an offeringSEC ↗
2026-04-23Issuer (share issuance)priced an offeringSEC ↗
2026-04-20Issuer (share issuance)priced an offeringSEC ↗
2026-03-13President and Chief Executive Officer Howard W. Robinadopted a selling planSEC ↗
2026-03-13Dr. Zalevskyadopted a selling planSEC ↗
2026-03-13Former Officer (via Fidelity Brokerage Services LLC) Wilson Mark Andrewfiled notice to sell$5.7MSEC ↗
2026-02-18President & CEO ROBIN HOWARD Wsold$31KSEC ↗
2026-02-18Chief R&D Officer Zalevsky Jonathansold$13KSEC ↗
2026-02-18Officer (via Fidelity Brokerage Services LLC) Zalevsky Jonathanfiled notice to sell$13KSEC ↗
2026-02-18Officer (via Fidelity Brokerage Services LLC) ROBIN HOWARD Wfiled notice to sell$31KSEC ↗
2026-01-20Chief R&D Officer Zalevsky Jonathansold$138KSEC ↗
2026-01-20Chief Research and Development Officer Jonathan Zalevsky, Ph.Dterminated a selling planSEC ↗
2026-01-20Officer (via Fidelity Brokerage Services LLC) Zalevsky Jonathanfiled notice to sell$138KSEC ↗
2025-11-25President & CEO ROBIN HOWARD Wsold$120KSEC ↗
2025-11-25Chief Legal Officer Wilson Mark Andrewsold$34KSEC ↗
2025-11-25Chief R&D Officer Zalevsky Jonathansold$63KSEC ↗

33 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals